ESR1 and breast cancer: In another study, CRISPR/Cas tool was employed to generate wild-type cells from ERα positive ZR75–1 cells containing the rs9940645 variant, which shows more responsiveness to different drugs such as raloxifene, olaparib, and cisplatin in BC patients [75].